MMP9 and Myocardial fibrosis: Moreover, MI promoted myocardial fibrosis dramatically, by increasing collagen deposition and upregulated the expression of fibrotic markers including MMP9, collagen type I, and α-SMA, the effects of which were alleviated by FSTL1 administration (Figures 4A–H).